ReviewChemistry (Weinheim an der Bergstrasse, Germany)2026
Carbon Dots for Cancer Theranostics: Synthesis Strategies, Luminescence Properties, and Advances in Bioimaging-Guided Diagnosis and Therapy.
Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Carbon dots (CDs) have emerged as a transformative class of luminescent nanomaterials for biomedical applications, offering superior biocompatibility, photostability, and tunability compared to conventional organic dyes and inorganic quantum dots. This review distinguishes itself by establishing a critical "Structure-Property-Application" feedback framework. We comprehensively summarize the rational design of CDs, specifically elucidating how core size, surface chemistry, and heteroatom doping can be precisely engineered to tailor optical emission into the near-infrared II window. Furthermore, the versatile roles of CDs in cancer theranostics are critically discussed, encompassing their utility in subcellular tracking, image-guided surgery, and multifunctional therapeutic platforms such as photothermal therapy (PTT), photodynamic therapy (PDT), and targeted drug delivery. Finally, we address the current challenges regarding scalability, reproducibility, and biosafety, providing a perspective on the future roadmap for the clinical translation of high-performance CD-based agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.